Get the Stockscreener App
396.09
0.54%
-2.16
After Hours:
396.09
Overview
News
Price History
Option Chain
Financials
Why ELV Down?
Discussions
Forecast
Stock Split
Dividend History
Elevance Health Inc stock is traded at $396.09, with a volume of 1.17M.
It is down -0.54% in the last 24 hours and down -0.70% over the past month.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$398.25
Open:
$400
24h Volume:
1.17M
Relative Volume:
0.92
Market Cap:
$85.90B
Revenue:
$201.11B
Net Income/Loss:
$4.95B
P/E Ratio:
17.60
EPS:
22.4991
Net Cash Flow:
$6.29B
1W Performance:
-3.62%
1M Performance:
-0.70%
6M Performance:
+33.77%
1Y Performance:
+25.07%
1-Day Range:
$394.69
$405.13
1-Week Range:
$394.31
$412.75
52-Week Range:
$274.84
$436.24
Elevance Health Inc Stock (ELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
(800) 331-1476
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
396.09 | 85.90B | 201.11B | 4.95B | 6.29B | 22.50 |
UNH
Unitedhealth Group Inc
|
376.59 | 338.03B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
89.13 | 113.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
CI
Cigna Group
|
272.01 | 71.88B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
397.93 | 47.78B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-08-26 | Initiated | Evercore ISI | In-line |
| Feb-03-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-08-26 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-21-25 | Downgrade | Argus | Buy → Hold |
| Jul-18-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-17-25 | Upgrade | Argus | Hold → Buy |
| Jan-22-25 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-18-24 | Downgrade | Argus | Buy → Hold |
| Jul-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-24-24 | Initiated | Morgan Stanley | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-28-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
View All
Elevance Health Inc Stock (ELV) Latest News
The American Journal of Managed Care® announces Aaron L. Schwartz, M.D., Ph.D., as 2026 Emerging Leader in Managed Care Research Award recipient - GlobeNewswire Inc.
Elevance Health stock heads into the open after a 0.8 percent gain - AD HOC NEWS
Elevance Health stock carries a USD 27 adjusted EPS outlook - ad-hoc-news.de
AM Best withdraws ratings of Elevance Health's Hawaii captive - Captive Insurance Times
Elevance Health stock heads into the open after a 0.45 percent drop - ad-hoc-news.de
Elevance Health stock gains 2.1 percent on September 22 - ad-hoc-news.de
Elevance Health stock heads into the open after a 2.1 percent gain - ad-hoc-news.de
Elevance Health stock holds near its yearly high - ad-hoc-news.de
Elevance Health (ELV) Slips 0.80% to $410.95 as Shares Trade Between Key LevelsBPI Bull Correction - siam.in
Gail Boudreaux | Elevance Health CEO & Former Dartmouth Basketball Star - Britannica
Elevance Health stock gains as FY 2026 EPS guidance trails consensus - ad-hoc-news.de
Elevance Health (ELV) Stock May Be Below Fair Value As Guidance Was Reaffirmed - Yahoo Finance
Elevance Health stock gains as FY 2026 EPS guidance trails consensus slightly - AD HOC NEWS
Elevance Health (ELV) Q2 2026 Earnings Call Transcript - fortune.com
NY Surgeons Say Elevance Penalty Policy Is Anticompetitive - Law360
Elevance Health sued again over out-of-network penalty - Modern Healthcare
Can Carelon Drive Elevance Health's Future Earnings Growth? - Eastern Progress
Elevance Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year? - Yahoo Finance
Elevance Health, Inc. (ELV) Stock forecasts - Yahoo Finance Australia
Why Does Elevance Health (NYSE:ELV) Matter in S&P 500? - Kalkine Media
Elevance leads UBS health benefits survey as employers brace for higher costs (ELV:NYSE) - Seeking Alpha
BofA Securities Adjusts Elevance Health Price Target to $480 From $460 - Moomoo
Elevance Health stock gains after reaffirmed 2026 earnings guidance - ad-hoc-news.de
Elevance Health Reaffirms 2026 Earnings and Cost Guidance - The Globe and Mail
Up 36% in the Last 12 Months, Does Elevance Health Stock Have More Room to Run Through 2028? - Yahoo Finance
ELV (Elevance Health) 5-Year EBITDA Growth Rate : 5.30% (As of Jun. 2026) - GuruFocus
Elevance Health Inc (ELV) Shares Surge 5.0% -- What GF Score of 90 Tells Investors - GuruFocus
ELV Stock Steadies As Oppenheimer Meeting Nears - StocksToTrade
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Should You Buy Elevance Health Stock For The Margin It Lost? - Trefis
Elevance Health reaffirms FY26 EPS guidance, shares rise 5% - scanx.trade
Elevance Health stock gains after 2026 earnings guidance is reaffirmed - ad-hoc-news.de
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation - Benzinga
Why is Elevance Health stock surging today? By Investing.com - Investing.com Nigeria
Elevance Health Inc Stock (ELV) Moved Up by 5.50% on Sep 10: Drivers Behind the Movement - TradingKey
Elevance Health reaffirms 2026 earnings and benefit expense guidance By Investing.com - Investing.com South Africa
Elevance Health reaffirms 2026 earnings and benefit expense guidance - Investing.com
Form 8K Elevance Health Inc For: 10 September By Investing.com - Investing.com Nigeria
Elevance Health Gains as Investors Revisit Medicare Advantage Tailwinds - Quiver Quantitative
Elevance Health (ELV) Reaffirms 2026 Earnings Guidance of at Lea - GuruFocus
Elevance holds loss ratio guidance above 90% as fall renewals near - Insurance Business
Elevance Health at Wells Fargo conference: growth plan stays on track - Investing.com UK
Elevance Health Inc's Dividend Analysis - GuruFocus
Elevance Health (NYSE: ELV) sticks with its 2026 profit target - Stock Titan
Elevance Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
Elevance Health stock falls amid sector worries over rising medical costs - ad-hoc-news.de
Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $488 - Moomoo
Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Elevance Health EVP and Chief Legal Officer Wessling Erin M Forfeits 349 Shares, Retains 7,230 Shares - Kalkine Media
2 Reasons to Watch ELV and 1 to Stay Cautious - Yahoo Finance
Elevance Health Inc Stock (ELV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.45%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):